Safe Time for Apnea After Preoxygenation (STAP)

November 28, 2022 updated by: Zijia Li, Sixth Affiliated Hospital, Sun Yat-sen University

Safe Time for Apnea After Preoxygenation With Different Oxygen Concentration During the Induction of General Anesthesia

The use of 100% oxygen during the induction of general anesthesia is always preferable to have enough time to secure the airway by endotracheal intubation, because preoxygenation with a low oxygen concentration may reduce the safe time for apnea. However, using a low oxygen concentration during preoxygenation might prevent the formation of atelectasis. There is still no clear conclusion about the best oxygen concentration for preoxygenation. Our study is designed to evaluate the safety of preoxygenation with 80%, 60%, 40%, 30% and 21% oxygen by the safe time for apnea during the induction of general anesthesia.

Study Overview

Detailed Description

We decide to add 3 groups (80%, 60%, and 40% oxygen) in our study to fully evaluate the safety of preoxygenation with different oxygen concentration.

Zijia Li 2018.3.2

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510655
        • Department of Anesthesia ,the Sixth Affiliated Hospital of Sun Yat-sen University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Nonsmoking patients aged 18 years to 60 years
  • Undergoing general anesthesia for elective surgery
  • Pulse oxygen saturation ≥95% when breathing air quietly in bed
  • American Society of Anesthesiologists(ASA) physical status class I-II
  • Informed consent can be obtained

Exclusion Criteria:

  • A suspected difficult airway
  • Be allergic to midazolam, propofol , fentanyl or Cisatracurium
  • Severe disease of respiratory system or cardiovascular system,or obstruction of the digestive tract
  • Oxygen reserve is suspected low,or patient who does not tolerate hypoxemia well
  • A history of mental disorder or patient who can not collaborate well
  • Body mass index more than 30 kg/㎡

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: group A
100% Oxygen
Conventional preoxygenation with 100% oxygen
Other Names:
  • 100% O2
EXPERIMENTAL: group B
30% Oxygen.
preoxygenation with 30% oxygen
Other Names:
  • 30% O2
EXPERIMENTAL: group C
21% Oxygen
preoxygenation with 21% oxygen
Other Names:
  • 21% O2
EXPERIMENTAL: group D
40% Oxygen
preoxygenation with 40% oxygen
Other Names:
  • 40% O2
EXPERIMENTAL: group E
60% Oxygen
preoxygenation with 60% oxygen
Other Names:
  • 60% O2
EXPERIMENTAL: group F
80% Oxygen
preoxygenation with 80% oxygen
Other Names:
  • 80% O2

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Safe time for apnea
Time Frame: 10 min
Time when peripheral oxygen saturation (SpO2) is ≥ 90% after preoxygenation.
10 min

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time needed for endotracheal intubation
Time Frame: 1 min
Time from when the laryngoscope blade first passes the lips to when the cuff of tracheal tube is inflated.
1 min

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Zijia Li, Sixth Affiliated Hospital, Sun Yat-sen University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 1, 2017

Primary Completion (ACTUAL)

December 30, 2017

Study Completion (ACTUAL)

December 30, 2017

Study Registration Dates

First Submitted

July 30, 2017

First Submitted That Met QC Criteria

August 2, 2017

First Posted (ACTUAL)

August 4, 2017

Study Record Updates

Last Update Posted (ACTUAL)

November 29, 2022

Last Update Submitted That Met QC Criteria

November 28, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2017ZSLYEC-022

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia, General

Clinical Trials on 100% Oxygen

3
Subscribe